Collegium Pharmaceutical, Inc. (COLL)

Collegium Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 13, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,447	924	1,004	779	650	693
Market Cap Growth	38.05%	-7.95%	28.87%	19.82%	-6.16%	0.39%
Enterprise Value	2,098	1,797	1,418	1,377	727	804
Last Close Price	45.79	28.65	30.78	23.20	18.68	20.03
PE Ratio	28.17	13.35	20.84	-	9.09	25.89
Forward PE	6.03	4.54	5.57	4.01	4.57	4.88
PS Ratio	1.92	1.46	1.77	1.68	2.35	2.23
PB Ratio	5.27	4.04	5.14	4.00	3.20	3.72
P/FCF Ratio	5.00	4.54	3.66	6.35	6.40	7.84
P/OCF Ratio	4.98	4.51	3.65	6.27	6.28	7.37
PEG Ratio	-	0.16	0.16	0.17	1.08	0.21
EV/Sales Ratio	2.77	2.85	2.50	2.97	2.63	2.59
EV/EBITDA Ratio	5.23	4.87	4.17	7.99	7.98	6.83
EV/EBIT Ratio	11.99	9.00	7.44	36.13	32.76	14.30
EV/FCF Ratio	7.25	8.84	5.17	11.23	7.16	9.10
Debt / Equity Ratio	3.41	4.28	3.45	3.64	1.27	1.43
Debt / EBITDA Ratio	2.31	2.63	1.96	4.04	2.75	2.21
Debt / FCF Ratio	3.24	4.82	2.46	5.78	2.55	3.02
Net Debt / Equity Ratio	2.37	3.57	1.86	2.75	0.36	0.50
Net Debt / EBITDA Ratio	1.62	2.22	1.07	3.11	0.79	0.79
Net Debt / FCF Ratio	2.25	4.02	1.33	4.37	0.71	1.05
Asset Turnover	0.47	0.45	0.49	0.50	0.41	0.65
Inventory Turnover	2.35	2.46	2.02	3.70	3.58	5.50
Quick Ratio	1.15	0.77	1.07	0.82	1.05	1.08
Current Ratio	1.36	0.95	1.17	0.97	1.13	1.16
Return on Equity (ROE)	22.96%	32.62%	24.68%	-12.57%	36.77%	19.56%
Return on Assets (ROA)	6.75%	8.89%	10.28%	2.55%	2.08%	7.40%
Return on Invested Capital (ROIC)	13.41%	17.46%	18.80%	7.58%	8.02%	50.15%
Return on Capital Employed (ROCE)	15.20%	17.30%	27.80%	5.10%	5.40%	13.90%
Earnings Yield	4.04%	7.49%	4.80%	-3.21%	11.00%	3.86%
FCF Yield	19.99%	22.01%	27.33%	15.74%	15.63%	12.76%
Buyback Yield / Dilution	13.26%	3.26%	-23.53%	17.58%	-16.77%	-5.07%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q